CSG Delivers on Poland Munitions Pact but NATO Rally Fails to Lift Stock From 62% Slump

Czech defense contractor CSG completes propellant tech transfer to Poland, but shares remain near 52-week lows amid sector skepticism and short-seller fallout.

Operationally, the Czechoslovak Group keeps chalking up wins. The Czech defense contractor has just completed a critical technology transfer to Poland’s state-owned arms maker MESKO, handing over know-how for the production of modular propellant charges used in 155-millimeter artillery shells. The move, part of a December 2023 pact, saw CSG engineers help start a new production line and oversee the first trial batch on site. It is a concrete step toward building self-sufficient ammunition supply chains on NATO’s eastern flank — and proof that CSG’s partnership agreements are translating into real projects.

Yet at the bourse, that positive signal has been largely ignored. CSG shares were fetching €13.65 on Friday, a modest 1.07% gain from the previous close of €13.51. The advance barely registers against a brutal correction that has lopped 62% off the stock since its 52-week high of €36.05, set on January 26. The 52-week low of €12.20, touched on June 26, lies just 11.88% below the current price, underscoring how close the equity is to fresh lows.

The defense sector had every reason to rally this week. NATO’s two-day summit in Ankara concluded with some of the most concrete procurement commitments the alliance has made in years: fresh orders worth over €50 billion, a $40 billion-plus drone-defense program dubbed NATO Drone Edge, and a pledge of €70 billion in military aid, equipment and training for Ukraine in 2026, with at least the same level to follow in 2027. NATO Secretary-General Mark Rutte presented the summit as proof that announcements were turning into actual contracts, insisting that “results are already being delivered” a year after the Hague gathering.

European defense stocks failed to join the party, however. The decision by Amsterdam-listed tank maker KNDS to postpone its initial public offering — it had been slated for a valuation above €12 billion — soured the mood well before the summit began. KNDS said it would wait for “more favorable market conditions,” feeding investor doubts about whether the much-vaunted European defense boom can live up to its billing. CSG, which competes with KNDS in land systems and ammunition, is caught in the same downdraft.

Amid that skepticism, the market has not forgotten the short-seller report that hammered the stock shortly after January’s IPO. The report alleged gaps in CSG’s disclosure practices, triggering a sell-off that erased months of gains in days. While the company has pushed ahead with new ventures — including a recent push into the United States with fresh subsidiaries — the stain on investor confidence has lingered.

Technical readings offer little clarity. The 50-day moving average sits at €15.46, well above the current price, highlighting the depth of the post-IPO correction. The relative strength index of 42.2 points to neither overbought nor oversold conditions. With an annualized volatility of 51.68%, the stock remains highly reactive to news flow — but it is also waiting for hard evidence that headline numbers from Ankara will become signed contracts for CSG’s subsidiaries.

Over the past seven trading sessions, the stock lost 6.44%; on a monthly basis it is down 4.84%. The summit in Ankara reaffirms the long-term demand narrative that underpins CSG’s build-out in munitions, land systems and chemical supply chains. But with the KNDS IPO shelved and sector sentiment fragile, investors are holding fire until the next quarterly report delivers unmistakable order data — ideally showing that the Polish technology transfer and other operational wins are starting to flow through to the bottom line.